JG
RPTP

Joel Greenblatt’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Joel Greenblatt’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-16,756
Closed -$150K – 1145
2016
Q3 		$150K Buy
+16,756
New +$119K ﹤0.01% 881
2015
Q3 		– Sell
-18,396
Closed -$290K – 1139
2015
Q2 		$290K Buy
+18,396
New +$223K ﹤0.01% 823
2014
Q4 		– Sell
-22,595
Closed -$217K – 1165
2014
Q3 		$217K Buy
+22,595
New +$231K ﹤0.01% 910

Joel Greenblatt's RPTP Position: Q4 2016 in Review

Joel Greenblatt sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 16,756 shares — an estimated $150K sold.

Joel Greenblatt first reported a position in RPTP in Q3 2014 and held it in 3 quarters. The position peaked at $290K in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Joel Greenblatt reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Joel Greenblatt sold 16,756 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $150K.
  • Joel Greenblatt first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • Joel Greenblatt's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $290K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Gotham Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.